Home
Bafna Pharmaceuticals Ltd PE Ratio

Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
PE
Key Highlights
- The P/E Ratio of Bafna Pharmaceuticals Ltd is 37.5 as of 22 Feb 15:30 PM .
- The P/E Ratio of Bafna Pharmaceuticals Ltd is 0 as of March 2020 .
- The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 71.95 as of 20 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
PE
Company Fundamentals for Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd
NSE: BAFNAPH
Share Price
Market Price of Bafna Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
20 Feb 2025 | 71.95 |
18 Feb 2025 | 68.54 |
17 Feb 2025 | 71.36 |
14 Feb 2025 | 75 |
13 Feb 2025 | 78.79 |
12 Feb 2025 | 78.79 |
11 Feb 2025 | 75.1 |
10 Feb 2025 | 78.35 |
05 Feb 2025 | 79.36 |
04 Feb 2025 | 79.36 |
SWOT Analysis Of Bafna Pharmaceuticals Ltd
BlinkX Score for Bafna Pharmaceuticals Ltd
Asset Value vs Market Value of Bafna Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Bafna Pharmaceuticals Ltd | 174.58 | 37.46 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Bafna Pharmaceuticals Ltd | 174.58 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Bafna Pharmaceuticals Ltd Explained
₹174.58
Market cap
₹4
Earnings
37.5X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Bafna Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Bafna Pharmaceuticals Ltd
Historical Revenue, EBITDA and Net Profit of Bafna Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Bafna Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Bafna Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Bafna Pharmaceuticals Ltd
About Bafna Pharmaceuticals Ltd
- Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
- The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
- Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
- During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.
Bafna Pharmaceuticals Ltd News Hub
Bafna Pharmaceuticals reports standalone net loss of Rs 0.72 crore in the June 2024 quarter
Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as agains
Read more
13 Aug 24
Bafna Pharmaceuticals to declare Quarterly Result
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
10 Aug 24
Bafna Pharmaceuticals to convene AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
04 Sept 24
Bafna Pharmaceuticals schedules AGM
Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on
Read more
05 Sept 24